常用連結
1734
杏輝
生技醫療業
TWSE
2026-05-29
| 年月 |
當月營收 |
月增率 |
年增率 |
累計營收 |
累計年增率 |
走勢 |
| 2026/04 |
291,461 |
-8.11%
|
+7.56%
|
1,117,697 |
+3.81%
|
|
| 2026/03 |
317,169,000 |
+61.56%
|
+5.08%
|
826,236 |
+2.55%
|
|
| 2026/02 |
196,311,000 |
-37.23%
|
-17.36%
|
509,067,000 |
+1.03%
|
|
| 2026/01 |
312,756,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/12 |
291,303,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/11 |
272,558,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/10 |
289,331,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/09 |
209,681,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/08 |
280,388,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/07 |
261,180,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/06 |
269,177,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/05 |
257,028,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/04 |
241,286,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/03 |
267,025,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/02 |
207,167,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2024/01 |
303,726,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/12 |
246,928,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/11 |
262,875,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/10 |
238,270,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/09 |
265,696,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/08 |
227,103,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/07 |
224,786,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/06 |
222,942,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/05 |
264,870,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/04 |
239,580,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/03 |
329,968,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/02 |
212,309,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 2023/01 |
228,663,000 |
0.00%
|
0.00%
|
— |
0.00%
|
|
| 序 |
持股/單位數分級 |
人數 |
股數/單位數 |
占集保庫存(%) |
比例 |
| 1 |
1-999 |
56,079 |
2,015 |
1.05% |
|
| 2 |
1,000-5,000 |
12,157 |
23,174 |
12.18% |
|
| 3 |
5,001-10,000 |
1,799 |
12,168 |
6.39% |
|
| 4 |
10,001-15,000 |
755 |
9,003 |
4.73% |
|
| 5 |
15,001-20,000 |
243 |
4,271 |
2.24% |
|
| 6 |
20,001-30,000 |
319 |
7,768 |
4.08% |
|
| 7 |
30,001-40,000 |
130 |
4,526 |
2.37% |
|
| 8 |
40,001-50,000 |
75 |
3,375 |
1.77% |
|
| 9 |
50,001-100,000 |
155 |
10,678 |
5.61% |
|
| 10 |
100,001-200,000 |
82 |
10,865 |
5.71% |
|
| 11 |
200,001-400,000 |
49 |
14,140 |
7.43% |
|
| 12 |
400,001-600,000 |
13 |
6,248 |
3.28% |
|
| 13 |
600,001-800,000 |
7 |
4,797 |
2.52% |
|
| 14 |
800,001-1,000,000 |
4 |
3,556 |
1.87% |
|
| 15 |
1,000,001以上 |
17 |
73,607 |
38.70% |
|
| 公司名稱 | 杏輝 |
| 英文簡稱 | SINPHAR |
| 產業類別 | 生技醫療業 |
| 市場別 | 上市（TWSE） |
| 所屬集團 | — |
| 成立時間 | 1977-07-02 |
| 掛牌日期 | 2002-08-26 |
| 董事長 | 李志文 |
| 總經理 | 白友烺 |
| 發言人 | 陳至孝 |
| 代理發言人 | 李宛頻 |
| 總機電話 | (03)958-1101 |
| 傳真號碼 | (03)9580-187 |
| 電子郵件 | info@sinphar.com |
| 公司網站 |
www.sinphar.com
|
| 公司地址 | 宜蘭縣冬山鄉中山村中山路八十四號 |
| 股務代理 | 永豐金證券(股)公司股務代理部 |
| 簽證會計師 | 國富浩華聯合會計師事務所 |
| 股本 | 1,901,967,740 元 |
| 已發行普通股數 | 190,196,774 股 |
| 董監持股比例 | — |
| 市值 | 58.39 億元 |
52 週價格區間
目前位置 26.5%
低 29.80
高 33.20